SALURON Drug Patent Profile
✉ Email this page to a colleague
When do Saluron patents expire, and what generic alternatives are available?
Saluron is a drug marketed by Shire Llc and is included in one NDA.
The generic ingredient in SALURON is hydroflumethiazide. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide profile page.
Summary for SALURON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Patent Applications: | 4,359 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SALURON at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SALURON
US Patents and Regulatory Information for SALURON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire Llc | SALURON | hydroflumethiazide | TABLET;ORAL | 011949-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |